Doç. Dr. Enver Sinan Albayrak

Doç. Dr. Enver Sinan Albayrak2018-08-09T11:35:29+00:00
Doç. Dr. Enver Sinan Albayrak
Doç. Dr. Enver Sinan Albayrak Kardiyoloji

Hekim Özgeçmişi

Doğum Yeri ve Tarihi

Siirt, 1945

Bildiği Yabancı Diller

İngilizce

Eğitim ve Uzmanlık

Dokuz Eylül Üniversitesi
Abant İzzet Baysal Üniversitesi Düzce Tıp Fakültesi

Vaka Deneyimi

5000’in Üzerinde Koroner Anjiyografi, 1000’in Üzerinde Koroner Stent 300’in Üzerinde Kalp Pili,

Üyesi Olduğu Dernekler

TKD, TTB, ESC

Bilimsel Yayın ve Çalışmaları

  1. Albayrak S, Ozhan H, Aslantas Y, Ekinozu I, Tibilli H, Kayapinar O; Melen Study Investigators. Predictors of major adverse cardiovascular events; results of population based MELEN study with prospective follow-up. Eur Rev Med Pharmacol Sci. 2015 Apr;19(8):1446-51.
  2. Cil H, Bulur S, Türker Y, Kaya A, Alemdar R, Karabacak A, Aslantaş Y, Ekinözü I, Albayrak S, Ozhan H; MELEN Investigators. impact of body mass index on left ventricular diastolic dysfunction. 2012 Jul;29(6):647-51. doi: 10.1111/j.1540-8175.2012.01688.x. Epub 2012 Apr 4.
  3. Ozhan H, Alemdar R, Caglar O, Ordu S, Kaya A, Albayrak S, Turker Y, Bulur S; MELEN Investigators. Performance of bioelectrical impedance analysis in the diagnosis of metabolic syndrome. Investig Med. 2012 Mar;60(3):587-91. doi: 10.2310/JIM.0b013e318244e2d9.
  4. Bulur S, Ozhan H, Albayrak ES, Türker Y. [Comment on: Turkey’s publication output in cardiovascular medicine declined in 2010 both in quantity and quality (Turk Kardiyol Dern Ars 2011;39:72-84)]. Turk Kardiyol Dern Ars. 2011 Apr;39(3):259
  5. Satılmışoğlu H, Ozhan H, Albayrak S, Kaya A, Erden I, Yazıcı M. Relation of asymmetric dimethylarginine levels with conventional risk score systems in the healthy subjects with positive family history for coronary artery disease]. Anadolu Kardiyol Derg. 2011 Mar;11(2):114-8. doi: 10.5152/akd.2011.029. Epub 2011 Feb 2. Turkish.
  6. Albayrak S, Ordu S, Yuksel H, Ozhan H, Yazgan O, Yazici M. Efficacy of nebivolol on flow-mediated dilation in patients with slow coronary flow. Int Heart J. 2009 Sep;50(5):545-53.
  7. Albayrak S, Ordu S, Ozhan H, Yazici M, Aydin M, Alemdar R, Kaya A. Effect of olmesartan medoxomil on cystatin C level, left ventricular hypertrophy and diastolic function. Blood Press. 2009;18(4):187-91. doi: 10.1080/08037050903047236.
  8. Onat A, Ozhan H, Erbilen E, Albayrak S, Küçükdurmaz Z, Can G, Keleş I, Hergenç G. Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels. Int J Cardiol. 2009 Jun 26;135(2):211-7. doi: 10.1016/j.ijcard.2008.03.054. Epub 2008 Jun 25.
  9. Onat A, Hergenc G, Karabulut A, Albayrak S, Can G, Kaya Z.Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women. Metabolism. 2007 Oct;56(10):1356-62. PMID: 17884445
  10. Onat A, Ozhan H, Can G, Hergenc G, Karabulut A, Albayrak S. Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks. Anadolu Kardiyol Derg. 2007;7:128-133 PMID: 17513206
  11. Ozhan H, Albayrak S, Uzun H, Ordu S, Kaya A, Yazici M.‘’Correlation of plasma B-type natriuretic peptide with shunt severity in patients with atrial or ventricular septal defect. Pediatr Cardiol. 2007 Jul-Aug;28(4):272-5. Epub 2007 May 25. PMID: 17530321
  12. Onat A, Hergenc G, Uyarel H, Ozhan H, Esen AM, Karabulut A, Albayrak S, Can G,Keles I. Association between mild renal dysfunction and insulin resistance or metabolic syndrome in a random nondiabetic population sample. Kidney Blood Press Res. 2007;30(2):88-96. Epub 2007 Mar 7. PMID: 17347575
  13. Onat A, Can G, Hergenc G, Yazici M, Karabulut A, Albayrak S.’’Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Int J Obes (Lond). 2007 Jul;31(7):1119-25. Epub 2007 Feb 13. PMID: 17299378
  14. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I, Yazici M, Keles I. Serum uric acid is a determinant of metabolic syndrome in a population-based study.Am J Hypertens. 2006 Oct;19(10):1055-62. PMID: 17027827
  15. Yavuz MT, Yavuz O, Yazici M, Guler S, Ozhan H, Albayrak S, Coskun A. Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis. Scand J Clin Lab Invest. 2006;66(6):523-34. PMID: 17000560
  16. Onat A, Ozhan H, Esen AM, Albayrak S, Karabulut A, Can G, Hergenc G. Prospective epidemiologic evidence of a “protective” effect of smoking on metabolic syndrome and diabetes among Turkish women–without associated overall health benefit. Atherosclerosis. 2007 Aug;193(2):380-8. Epub 2006 Aug 22. PMID: 16926017
  17. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis. 2007 Mar;191(1):182-90. Epub 2006 May 6. PMID: 1667883
  18. Ozhan H, Yazici M, Albayrak S, Erbilen E, Bulur S, Akdemir R, Uyan C. Elastic properties of the ascending aorta and left ventricular function in patients with hypothyroidism. Echocardiography. 2005 Sep;22(8):649-56 PMID: 16174118
  19. Yazici M, Norgaz T, Akdemir R, Albayrak S. Asymptomatic giant left atrial myxoma supplied from right coronary artery in a 65-year-old woman. Int J Cardiol. 2005 Jun 8;101(3):495-6. PMID: 15907421
  20. Gunduz H, Akdemir R, Tataroglu C, Albayrak S, Erbilen E, Akdemir N, Yilmaz H, Uyan C. ‘’Myocardial bridging of obtuse marginal branch of the left circumflex artery associated with congenital corrected transposition of the great arteries. Int J Cardiol. 2005 Feb 28;98(3):503-5. PMID: 15708187
  21. Akdemir R, Ozhan H, Gunduz H, Tamer A, Yazici M, Erbilen E, Albayrak S, Bulur S, Uyan C. Effect of reperfusion on P-wave duration and P-wave dispersion in acute myocardial infarction: primary angioplasty versus thrombolytic therapy Ann Noninvasive Electrocardiol. 2005 Jan;10(1):35-40. PMID: 15649235
  22. Akdemir R, Ozhan H, Erbilen E, Yazici M, Albayrak S, Gunduz H, Uyan C. Primary angioplasty without on-site surgical back-up: the first experience with mobile catheterization facility. J Invasive Cardiol. 2004 Nov;16(11):645-8. PMID: 15550736
  23. Akdemir R, Ozhan H, Gunduz H, Erbilen E, Yazici M, Duran S, Orkunoglu F,Albayrak S, Imirzalioglu N, Uyan C. HLA-DR B1 and DQ B1 polymorphisms in patients with coronary artery ectasia. Acta Cardiol. 2004 Oct;59(5):499-502. PMID: 15529553
  24. Akdemir R, Gunduz H, Erbilen E, Ozer I, Albayrak S, Unlu H, Uyan C. Atrial fibrillation after electrical shock: a case report and review.Emerg Med J. 2004 Nov;21(6):744-6. Review. PMID: 15496713
  25. Akdemir R, Ozhan H, Yazici M, Gunduz H, Erbilen E, Albayrak S, Uyan C. Three years of experience with a mobile angiograph in a center without on-site surgical back-up Ann Saudi Med. 2004 Jul-Aug;24(4):253-8. PMID: 15387488
  26. Yazici M, Arbak P, Balbay O, Maden E, Erbas M, Erbilen E, Albayrak S, Akdemir R, Uyan C. Relationship between arterial blood gas values, pulmonary function tests and treadmill exercise testing parameters in patients with COPD. Respirology. 2004 Aug;9(3):320-5. PMID: 15363002
  27. Yazici M, Ataoglu S, Makarc S, Sari I, Erbilen E, Albayrak S, Yazici S, Uyan C. The relationship between echocardiographic features of mitral valve and elastic properties of aortic wall and Beighton hypermobility score in patients with mitral valve prolapse. Jpn Heart J. 2004 May;45(3):447-60. PMID: 15240965
  28. 20: Yazici M, Gorgulu S, Sertbas Y, Erbilen E, Albayrak S, Yildiz O, Uyan C. Effects of thyroxin therapy on cardiac function in patients with subclinical hypothyroidism: index of myocardial performance in the evaluation of left ventricular function. Int J Cardiol. 2004 Jun;95(2-3):135-43. PMID: 15193811

ONLiNE RANDEVU

BİZİ ARAYIN